RE:RE:Bedrocan Australia bound? Chris Parry article.That new $1.50 valuation would be great indeed if BED eventually nails it. There are some serious behind the scenes things going on with this company. BED.bv has Europe, BED.ca gets first play in the rest of the globe. I have always speculated that International expansion was one of the ways to go for massive future growth. Glad to see they are doing this with little fanfare. Steady march onwards and upwards.
They are already in talks with Uruguay that will open up the South American market for BED product. If they nail this Australia one then that opens up the Asia / Pacific market. I can also bet they are looking at a move in the US market once things line up properly like laws and so on. They even have a presence in the Middle East too - see quotes below.
Here are a few interesting things from BED Canada CEO Marc Wayne that he has hinted at in the past:
"We’re playing the long game. We are looking down the line at opportunities
much bigger than those presently available, and the right way to take advantage of those is to be a serious entity holding to high standards now."
"On the clinical side, we have a variety of projects underway; nothing to announce yet but
we have clinical drug development processes on both sides of the Atlantic, and we’re finding ways to make those programs synergistic."
"Bedrocan product is already being used in a variety of things right now,
such as products in Israel being developed, and we have a clinical trial protocol underway with Health Canada, as we believe it’s critical to the success of the industry that we
develop this product into real medicines. We have Health Canada pre-approval on a clinical trial already, so it’s just about taking the next step in that process."
Source:
https://www.stockhouse.com/news/newswire/2014/12/19/bedrocan-v-bed-s-quality-push-%E2%80%9Cthey-re-growing-plants-we-re-growing-medicine-%E2%80%9D